Study finds ‘important shortcomings’ in official cancer drug information

Important information about cancer drug benefits, and related uncertainties, is frequently omitted from official prescription drug information sources for clinicians and patients in Europe, finds an analysis published by The BMJ today.

Leave A Comment

Your email address will not be published. Required fields are marked *